Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus

SGLT-2 inhibitor, traditionally used for glycemic control, has several beneficial effects that can help manage heart failure (HF). SGLT-2 inhibitors reduce the risk of cardiovascular mortality in patients with HF. As atrial fibrillation (AF) is closely associated with HF and diabetes mellitus (DM) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyuhyun, Lee, Soo Kyoung, Lee, Juyeon, Jeon, Bo Kyung, Kim, Tae-Hoon, Yu, Hee Tae, Lee, Jung Myung, Park, Jin-Kyu, Baek, Yong-Soo, Kim, Dong Hyeok, Shim, Jaemin, Joung, Boyoung, Lee, Moon-Hyoung, Pak, Hui-Nam, Park, Junbeom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847966/
https://www.ncbi.nlm.nih.gov/pubmed/36652465
http://dx.doi.org/10.1371/journal.pone.0280359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847966/
https://www.ncbi.nlm.nih.gov/pubmed/36652465
http://dx.doi.org/10.1371/journal.pone.0280359

Ejemplares similares